![Daniel Wallerstorfer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Daniel Wallerstorfer is a CEO & Chairman-Management Board at Darwin AG and a Chief Executive Officer at Novogenia GmbH.
Dr. Wallerstorfer was previously employed as a Co-Chief Executive Officer by Claya, Inc.
| Companies | Position | Start |
|---|---|---|
| NOVOGENIA AG | Chief Executive Officer | 2021-03-14 |
Novogenia GmbH
 Novogenia GmbH Miscellaneous Commercial ServicesCommercial Services Provides medical genetic testing services | Chief Executive Officer | 2008-12-31 |
| Companies | Position | End |
|---|---|---|
Claya, Inc.
 Claya, Inc. Food RetailRetail Trade Operates as an online store for nutrition and supplements | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Novogenia GmbH
Novogenia GmbH Miscellaneous Commercial ServicesCommercial Services Provides medical genetic testing services | Commercial Services |
Claya, Inc.
Claya, Inc. Food RetailRetail Trade Operates as an online store for nutrition and supplements | Retail Trade |
Darwin AG
 Darwin AG BiotechnologyHealth Technology Engages in research and development in the field of biotechnology | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
